Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP
Diagnostic challenges with PrEP use during early HIV infection
Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds
New PEP studies revive interest in post-exposure prevention
HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention
HIV drugs reduce feminising hormone levels by 36% in HIV-positive trans women, Thai study finds
Does PrEP cause more HIV drug resistance? Yes, some
PrEP in pregnancy: safe, but many unanswered questions
HIV PrEP could also lead to big reductions in gonorrhoea, Dutch study finds
